EH Estey
- Hematology top 1%
- Acute Myeloid Leukemia Research 14
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 6
- Oncology top 10%
- Neutropenia and Cancer Infections 5
- Cancer Treatment and Pharmacology 4
- Immunology top 10%
- Immunodeficiency and Autoimmune Disorders 3
-
- Retinoids in leukemia and cellular processes 5
- Advanced biosensing and bioanalysis techniques 3
-
- Acute Lymphoblastic Leukemia research 3
- Co-authors
- EJ FreireichMJ KeatingRazelle KurzrockKB McCredieYO HuhJF SeymourHM KantarjianAB Deisseroth
- Cited by
- HematologyGeneticsOncology
- Journals
- Blood (18 papers)Leukemia (2 papers)PubMed (5 papers)
- Partner nations
- United StatesAustralia
In The Last Decade
EH Estey
24 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 66
- Hematology 834
- Genetics 533
- Oncology 444
- Pathology and Forensic Medicine 275
- Immunology 290
Countries citing papers authored by EH Estey
This map shows the geographic impact of EH Estey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by EH Estey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites EH Estey more than expected).
Fields of papers citing papers by EH Estey
This network shows the impact of papers produced by EH Estey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by EH Estey. The network helps show where EH Estey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside EH Estey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 42 | |
| 2 | 2000 | 134 | |
| 3 | Incorporating new modalities into guidelines. Topotecan for myelodysplastic syndromes. | 1998 | 4 |
| 4 | Treatment of acute myelogenous leukemia and myelodysplastic syndromes. | 1995 | 21 |
| 5 | 1995 | 74 | |
| 6 | 1995 | 2 | |
| 7 | 1995 | 42 | |
| 8 | Prognostic value of residual normal metaphases in acute myelogenous leukemia patients presenting with abnormal karyotype. | 1995 | 7 |
| 9 | Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine. | 1995 | 36 |
| 10 | 1994 | 40 | |
| 11 | 1994 | 173 | |
| 12 | 1993 | 139 | |
| 13 | 1992 | 2 | |
| 14 | 1992 | 42 | |
| 15 | 1992 | 137 | |
| 16 | Platelet transfusion in aplastic patients: fatal thrombocytopenic hemorrhage in myeloblastic leukemia. | 1991 | 1 |
| 17 | 1990 | 39 | |
| 18 | 1989 | 9 | |
| 19 | 1982 | 33 | |
| 20 | 1982 | 158 |
About EH Estey
EH Estey is a scholar working on Hematology, Genetics, Oncology, Immunology and Biophysics, having authored 25 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), Chronic Lymphocytic Leukemia Research (6 papers), Neutropenia and Cancer Infections (5 papers), Retinoids in leukemia and cellular processes (5 papers), Cancer Treatment and Pharmacology (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). The work is most often cited by research in Hematology (834 citations), Genetics (533 citations), Oncology (444 citations), Pathology and Forensic Medicine (275 citations) and Immunology (290 citations). EH Estey has collaborated with scholars based in United States and Australia. Frequent co-authors include EJ Freireich, MJ Keating, Razelle Kurzrock, KB McCredie, YO Huh, JF Seymour, HM Kantarjian, AB Deisseroth, GP Bodey and David F. Claxton. Their work appears in journals such as Blood, Leukemia and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.